Intercept Pharmaceuticals
(NASDAQ) ICPT
Intercept Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$317.68M
Net Income (TTM)
$58.61M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ICPT News
Are These the Next Meme Stocks?
ICPT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Intercept Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
341
CEO
Jerome B. Durso
Website
www.interceptpharma.comHeadquarters
New York City, NY 10001, US
ICPT Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-24%
Net Income Margin
40%
Return on Equity
-3%
Return on Capital
-21%
Return on Assets
21%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$284.73M
Operating Income
$68.22M
EBITDA
$61.70M
Operating Cash Flow
$26.78M
Capital Expenditure
$568.00K
Free Cash Flow
$27.35M
Cash & ST Invst.
$490.91M
Total Debt
$332.67M
Intercept Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$88.79M
+14.4%
Gross Profit
$88.59M
+14.8%
Gross Margin
99.78%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
341
N/A
Net Income
$2.79M
-101.6%
EBITDA
$5.15M
+167.3%
Quarterly Fundamentals
Net Cash
$98.86M
-37.6%
Accounts Receivable
$32.48M
+24.1%
Inventory
$2.65M
-57.8%
Long Term Debt
$223.86M
+0.4%
Short Term Debt
$0.00
-100.0%
Return on Assets
20.80%
N/A
Return on Invested Capital
-21.08%
N/A
Free Cash Flow
$16.67M
+198.5%
Operating Cash Flow
$16.69M
+200.6%